Medera and Novoheart collaborate on mini-heart models for HLHS
Pharmaceutical Technology
JUNE 25, 2025
Medera and its subsidiary Novoheart have collaborated with scientists at the University of California San Diego School of Medicine and Mayo Clinic to develop mini-heart models for hypoplastic left heart syndrome (HLHS). Credit: shisu_ka/Shutterstock. Don’t let policy changes catch you off guard.
52 
Let's personalize your content